Xencor Inc At The American Society Of Hematology (ASH) Annual Meeting Transcript
(inaudible) Dr. Krish Patel, Director of the Lymphoma Program (inaudible) and Investigator for the ongoing baseline study will join us for (inaudible) which will be available for download on the Events and Presentation page of xencor.com.
First, so company management may make forward-looking statements during the presentation, which are subject to risk and uncertainties (inaudible) future results (inaudible) from what expressed or implied by these forward-looking statements. Xencor is (inaudible) obligation or undertaking (inaudible) update or revise these forward-looking statements.
You are encouraged to review risk factors (inaudible). Now, Dr. Bassil Dahiyat, President and Chief Executive Officer of Xencor will introduce the company (inaudible) the presentation (inaudible).
Do you hear me? That's me. So welcome everybody who's joining this evening. Thanks for coming (inaudible) very (inaudible). Welcome to everybody who's logged
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |